未登录

D

Didier Guillemot

universite de paris

H指数:48

被引数:7,782

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Modelling impacts of paediatric amoxicillin shortage management on pneumococcal resistance and invasive disease in Europe

模拟儿科阿莫西林短缺管理对欧洲肺炎链球菌耐药性和侵袭性疾病的影响

Nature Communications

IF15.7

2026-05-190

OAAI

Contribution of maternal gut carriage to neonatal acquisition of extended-spectrum beta-lactamase-producing Enterobacterales in Madagascar and Cambodia

母体肠道定植对马达加斯加和柬埔寨新生儿获得产超广谱β-内酰胺酶肠杆菌科细菌的贡献

Nature Communications

IF15.7

2025-11-240

OAAI

Impacts of the COVID-19 pandemic on sepsis incidence, etiology and hospitalization costs in France: a retrospective observational study

COVID-19大流行对法国脓毒症发病率、病因及住院费用的影响：一项回顾性观察性研究

BMC INFECTIOUS DISEASES

IF3

2025-04-290

OA

Evolution of social contacts patterns in France over the SARS-CoV-2 pandemic: results from the SocialCov survey

BMC INFECTIOUS DISEASES

IF3

2025-02-140

OAAI

Hospital population density and risk of respiratory infection: Is close contact density dependent?

IF2.4

2024-12-010

OA

Trends in hospitalisations for lower respiratory infections after the COVID-19 pandemic in France

JOURNAL OF INFECTION

IF11.9

2024-11-011

OAAI

Hospitalisations for lower respiratory tract infections in adults with and without chronic respiratory disease during and after COVID-19 pandemic

EUROPEAN RESPIRATORY JOURNAL

IF21

2024-10-300

PRE

Antimicrobial Resistance as Risk Factor for Recurrent Bacteremia after Staphylococcus aureus, Escherichia coli, or Klebsiella spp. Community-Onset Bacteremia

EMERGING INFECTIOUS DISEASES

IF6.6

2024-05-010

OAAI

Care pathways of sepsis survivors: sequelae, mortality and use of healthcare services in France, 2015-2018

IF9.3

2023-11-1010

OAAI

Incidence and risk factors of neonatal bacterial infections: a community-based cohort from Madagascar (2018-2021)

BMC INFECTIOUS DISEASES

IF3

2023-10-053

OAAI

Determinants ofworldwide antibiotic resistance dynamics across drug-bacterium pairs: a multivariable spatial- temporal analysis using ATLAS

跨药物-细菌对的全球抗生素耐药性动态的决定因素: 使用ATLAS的多变量时空分析

LANCET PLANETARY HEALTH

IF21.6

2023-07-019

OAAI

Vaccination Coverage and Risk Factors Associated With Incomplete Vaccination Among Children in Cambodia, Madagascar, and Senegal

OPEN FORUM INFECTIOUS DISEASES

IF3.8

2023-03-105

OAAI

Short treatment duration for community-acquired pneumonia

社区获得性肺炎治疗时间短

CURRENT OPINION IN INFECTIOUS DISEASES

IF4

2023-01-275

PRE

Antimicrobial Resistance and Mortality in Hospitalized Patients with Bacteremia in the Greater Paris Area from 2016 to 2019

clinical epidemiology

IF3.2

2022-12-013

OAAI

One-year hospital readmission for recurrent sepsis: associated risk factors and impact on 1-year mortality-a French nationwide study

IF9.3

2022-11-2913

OAAI

Contact patterns and HPV-genotype interactions yield heterogeneous HPV-vaccine impacts depending on sexual behaviors: An individual-based model

IF2.4

2022-06-013

OA

From Pathophysiological Hypotheses to Case-Control Study Design: Resistance from Antibiotic Exposure in Community-Onset Infections

ANTIBIOTICS-BASEL

IF4.6

2022-02-040

OAAI

Lockdown impact on age-specific contact patterns and behaviours, France, April 2020

EUROSURVEILLANCE

IF7.8

2021-12-027

OAAI

Antibiotic prescriptions and risk factors for antimicrobial resistance in patients hospitalized with urinary tract infection: a matched case-control study using the French health insurance database (SNDS) (vol 21, 571, 2021)

BMC INFECTIOUS DISEASES

IF3

2021-06-290

OAAI

Antibiotic prescriptions and risk factors for antimicrobial resistance in patients hospitalized with urinary tract infection: a matched case-control study using the French health insurance database (SNDS)

BMC INFECTIOUS DISEASES

IF3

2021-06-1410

OAAI